FSSAI Orders Dabur Audit on Health Claims for 27 Products
FSSAI mandates Dabur audit for 27 product lines over health claims. Scientific evidence required; compliance urged for consumer safety. Source: ScoutQuest
Stock news timeline · DABUR
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
Showing 12 of 12 updates · Newest first
Change the keyword or sentiment above, then click Apply.
FSSAI mandates Dabur audit for 27 product lines over health claims. Scientific evidence required; compliance urged for consumer safety. Source: ScoutQuest
FSSAI orders statutory audit of 27 Dabur India product lines. Audit linked to labeling compliance push by food safety regulator. Source: Livesquawk
Kotak Institutional Equities upgraded Dabur India to 'Add' after 25% stock price correction. Dabur's FY27 revenue/ EPS growth seen at 9-10%, FV revised to ₹430; ROE stands at 21.3%. Source: Livemint
Dabur India Ltd to participate in investor conferences on Sept 21-22, 2026 in Mumbai. No unpublished price-sensitive info will be disclosed; details available on Dabur's website. Source: BSE
FSSAI barred Dabur from using '100 Pure' labels after five notices. Decision followed regulatory communications spanning 2024-2026. Source: Hindustan Times
Dabur India receives ESG rating of 73, categorized as 'Leader' by NSE Sustainability. Rating independently prepared by NSE Sustainability, based on public data; disclosed under SEBI Regulation 30. Source: BSE
FMCG stocks like HUL, ITC, Dabur, Emami, Godrej Consumer hit 52-week lows, falling up to 3% due to volatile input costs. HUL Q1FY27 gross margin contracted 80bp to 49.5% amid inflation; sector's long-term growth supported by premiumisation and rural demand. Source: Business Standard
Dabur India Ltd fell for the 5th session, closing at Rs 384.05, down 0.56%. Stock dropped 26.3% YoY, underperforming Nifty (-1.3%) and Nifty FMCG (-16.9%). Source: Capital Market
Dabur India Ltd informs updates on Regulation 30 concerning SEBI Listing Regulations. Delhi HC extends stay on FSSAI's prohibitory order; next hearing on Dec 16, 2026. Source: BSE